BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with the net proceeds intended for gold bullion purchase, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers for the offering.
Offer Details
Shares of common stock (or pre-funded warrants) to be offered by the Company.
Use of Proceeds
Proceeds to be used for gold bullion purchase, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company acting as joint book-running managers of the offering.
- BioSig Technologies aims to enhance its financial position through the public offering.
- The acquisition of gold bullion aligns with the company's investment policy and strategic goals.
The proposed public offering signifies BioSig Technologies' commitment to growth and strategic investment decisions. The involvement of reputable book-running managers reinforces investor confidence in the offering.